Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled phase II study

Xiang-Yun Kong,Jian-Xun Lu,Xin Wen-yu,Jian Zhang,Qian-Lan Xu,Rongjun Zhang,Jing-Lin Mi,Shu-Fang Liao,Jin-Fang Fan,Xiao-Li Qin,Da-Cheng Yao,Hua-Ying Tang,Wei Jiang

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled phase II study

2019

Xiang-Yun Kong
Jian-Xun Lu
Xin Wen-yu
Jian Zhang
Qian-Lan Xu
Rongjun Zhang
Jing-Lin Mi
Shu-Fang Liao
Jin-Fang Fan
Xiao-Li Qin
Da-Cheng Yao
Hua-Ying Tang
Wei Jiang

Background The objective of this study was to evaluate the efficacy and safety of gemcitabine plus cisplatin concurrent chemoradiotherapy (CCRT) in patients with nasopharyngeal carcinoma.

Keywords:

Phases of clinical research
Chemotherapy regimen
Fluorouracil
Pharmacology
Nasopharyngeal carcinoma
Gemcitabine
Oncology
Cisplatin
Internal medicine
Medicine
Neutropenia
Regimen

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations